跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 131,926 条关于
“von Willebrand factor defects”
全部
131,926
临床试验
124,218
药物
1,290
机构
88
资讯
6,330
去年
KU Leuven Spin-off Hemastatx Develops First Therapy Targeting Root Cause of Severe Bleeding Disorder
去年
Hemab Therapeutics Advances Bleeding Disorder Pipeline with Promising Clinical Data at ISTH 2025
去年
FDA Expands Vonvendi Approval to Include Pediatric von Willebrand Disease Patients
3年前
Vega Therapeutics' VGA039 Receives FDA Orphan Drug Designation for Von Willebrand Disease
去年
Star Therapeutics' VGA039 Receives FDA Fast Track Designation for Von Willebrand Disease
11个月前
Star Therapeutics Secures $125M Series D to Advance Von Willebrand Disease Drug VGA039 Through Phase 3 Testing
5个月前
Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease
11个月前
Star Therapeutics Secures $125 Million Series D to Advance VGA039 Phase 3 Trial for von Willebrand Disease
10个月前
Star Therapeutics Reports Positive Phase 1/2 Data for VGA039 in von Willebrand Disease at ASH 2025
10个月前
Hemab Therapeutics Secures $157 Million Series C to Advance First-in-Class Treatments for Rare Bleeding Disorders
第 1 页，共 633 页
上一页
下一页
